Shandong Wohua Pharmaceutical Co Ltd (002107) — Strategic Asset Allocation Index
Shandong Wohua Pharmaceutical Co Ltd (002107) has a Strategic Asset Allocation Index of 46.6% as of September 2023. Strategic assets (PP&E of CN¥388.06 Million plus long-term investments of CN¥-) total CN¥388.06 Million, measured against net assets of CN¥833.29 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Shandong Wohua Pharmaceutical Co Ltd Strategic Asset Allocation Index (2006–2021)
This chart shows how Shandong Wohua Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2006 to 2021. As of September 2023, the index stands at 46.6%, representing strategic assets of CN¥388.06 Million against net assets of CN¥833.29 Million CNY. Explore Shandong Wohua Pharmaceutical Co Ltd cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Shandong Wohua Pharmaceutical Co Ltd (2006–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shandong Wohua Pharmaceutical Co Ltd from 2006 to 2021, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Shandong Wohua Pharmaceutical Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 48.2% | CN¥447.75 Million | CN¥447.75 Million | CN¥- | CN¥929.26 Million | ▼ -2.9 pp |
| 2020 | 51.1% | CN¥469.25 Million | CN¥469.25 Million | CN¥- | CN¥918.01 Million | ▲ +11.9 pp |
| 2019 | 39.2% | CN¥304.04 Million | CN¥304.04 Million | CN¥- | CN¥775.15 Million | ▲ +1.6 pp |
| 2018 | 37.6% | CN¥261.50 Million | CN¥261.50 Million | CN¥- | CN¥695.78 Million | ▲ +1.5 pp |
| 2017 | 36.0% | CN¥236.38 Million | CN¥236.38 Million | CN¥- | CN¥655.78 Million | ▼ -2.0 pp |
| 2016 | 38.0% | CN¥217.74 Million | CN¥217.74 Million | CN¥- | CN¥572.64 Million | ▼ -1.4 pp |
| 2015 | 39.4% | CN¥215.48 Million | CN¥215.48 Million | CN¥- | CN¥547.26 Million | ▲ +10.8 pp |
| 2014 | 28.6% | CN¥180.41 Million | CN¥180.41 Million | CN¥- | CN¥631.74 Million | ▼ -4.5 pp |
| 2013 | 33.1% | CN¥200.06 Million | CN¥200.06 Million | CN¥- | CN¥605.04 Million | ▼ -1.8 pp |
| 2012 | 34.9% | CN¥207.16 Million | CN¥207.16 Million | CN¥- | CN¥594.41 Million | ▼ -3.4 pp |
| 2011 | 38.2% | CN¥223.90 Million | CN¥223.90 Million | CN¥- | CN¥586.07 Million | ▲ +0.6 pp |
| 2010 | 37.6% | CN¥221.82 Million | CN¥221.82 Million | CN¥- | CN¥590.64 Million | ▲ +7.5 pp |
| 2009 | 30.0% | CN¥206.79 Million | CN¥206.79 Million | CN¥- | CN¥688.45 Million | ▼ -5.4 pp |
| 2008 | 35.5% | CN¥226.36 Million | CN¥226.36 Million | CN¥- | CN¥637.88 Million | ▼ -15.8 pp |
| 2007 | 51.3% | CN¥175.61 Million | CN¥175.61 Million | CN¥- | CN¥342.22 Million | ▼ -30.0 pp |
| 2006 | 81.3% | CN¥115.95 Million | CN¥115.95 Million | CN¥- | CN¥142.57 Million | — |